Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For Free Copy Portfolio
Close

ChemoMetec A/S (CHEMM)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
363.20 +19.60    +5.70%
31/05 - Closed. Currency in DKK ( Disclaimer )
Type:  Equity
Market:  Denmark
ISIN:  DK0060055861 
S/N:  17402479
  • Volume: 190,621
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 336.60 - 369.00
ChemoMetec 363.20 +19.60 +5.70%

CHEMM Candlestick Patterns

 
Dozens of bullish and bearish live candlestick chart patterns for the ChemoMetec A/S stock and use them to predict future market behavior. The ChemoMetec stock patterns are available in a variety of time frames for both long and short term investments. Gain a trading edge with the auto pattern recognition feature and gain an insight into what the patterns mean.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Customize

Candlestick Patterns

Time Frame
Pattern Indication
Type
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Bullish Engulfing 5H Current
Completed Patterns
Harami Cross Bearish 15 1 May 31, 2024 10:30AM
Three Outside Down 5H 2 May 31, 2024 12:00AM
Engulfing Bearish 5H 3 May 30, 2024 09:00AM
Doji Star Bearish 1H 4 May 31, 2024 06:00AM
Downside Gap Three Methods 1M 6 Nov 23
Engulfing Bearish 15 7 May 31, 2024 09:00AM
Shooting Star 30 9 May 31, 2024 06:00AM
Advance Block Bearish 1D 10 May 16, 2024
Harami Bullish 1H 10 May 30, 2024 08:00AM
Harami Cross 1H 10 May 30, 2024 08:00AM
Hanging Man 15 11 May 31, 2024 08:00AM
Morning Doji Star 1M 12 May 23
Abandoned Baby Bullish 1M 12 May 23
Bullish doji Star 1M 13 Apr 23
Dragonfly Doji 1M 13 Apr 23
Engulfing Bearish 5H 15 May 23, 2024 02:00AM
Upside Gap Three Methods 5H 15 May 23, 2024 02:00AM
Three Outside Up 1H 15 May 30, 2024 03:00AM
Bullish Engulfing 1W 16 Feb 04, 2024
Bullish Engulfing 1H 16 May 29, 2024 10:00AM
Falling Three Methods 1M 17 Dec 22
Belt Hold Bullish 5H 17 May 22, 2024 01:00AM
Three Black Crows 1D 18 May 02, 2024
Harami Cross 30 18 May 30, 2024 09:30AM
Engulfing Bearish 15 20 May 31, 2024 05:45AM
Three Black Crows 1W 21 Dec 31, 2023
Engulfing Bearish 5H 21 May 17, 2024 06:00AM
Shooting Star 5H 23 May 16, 2024 10:00AM
Inverted Hammer 5H 23 May 16, 2024 10:00AM
Three Outside Up 5H 23 May 16, 2024 10:00AM
Falling Three Methods 1D 24 Apr 24, 2024
Two Crows 15 25 May 31, 2024 04:30AM
Belt Hold Bearish 15 26 May 31, 2024 04:15AM
Three Outside Down 30 27 May 30, 2024 05:00AM
Falling Three Methods 1D 28 Apr 18, 2024
Bullish Engulfing 1H 28 May 28, 2024 06:00AM
Engulfing Bearish 30 28 May 30, 2024 04:30AM
Downside Gap Three Methods 1W 30 Oct 29, 2023
Doji Star Bearish 5H 31 May 13, 2024 07:00AM
Engulfing Bearish 1D 32 Apr 12, 2024
Bullish doji Star 1H 32 May 27, 2024 10:00AM
Three Outside Up 30 32 May 29, 2024 10:30AM
Homing Pigeon 15 32 May 30, 2024 10:45AM
Engulfing Bearish 5H 33 May 08, 2024 07:00AM
Engulfing Bearish 1H 33 May 27, 2024 09:00AM
Falling Three Methods 1H 33 May 27, 2024 09:00AM
Bullish Engulfing 30 33 May 29, 2024 10:00AM
Belt Hold Bullish 15 34 May 30, 2024 10:15AM
Inverted Hammer 15 34 May 30, 2024 10:15AM
Falling Three Methods 1W 37 Sep 10, 2023
Belt Hold Bullish 1D 37 Apr 05, 2024
Falling Three Methods 1H 37 May 27, 2024 05:00AM
Three Inside Up 1H 39 May 27, 2024 03:00AM
Three Inside Up 15 42 May 30, 2024 08:15AM
Engulfing Bearish 1M 43 Oct 20
Upside Gap Three Methods 1M 43 Oct 20
Falling Three Methods 1W 43 Jul 30, 2023
Bullish Engulfing 1D 43 Mar 25, 2024
Three Outside Up 1H 43 May 24, 2024 07:00AM
Harami Bullish 15 43 May 30, 2024 08:00AM
Harami Cross 15 43 May 30, 2024 08:00AM
Bullish Engulfing 1H 44 May 24, 2024 06:00AM
Three Inside Up 1W 45 Jul 16, 2023
Harami Cross 1W 46 Jul 09, 2023
Bullish doji Star 1W 46 Jul 09, 2023
Harami Bullish 1W 46 Jul 09, 2023
Bullish doji Star 30 46 May 29, 2024 03:30AM
Harami Cross 30 46 May 29, 2024 03:30AM
Engulfing Bearish 15 47 May 30, 2024 07:00AM
Three Outside Up 1M 48 May 20
Bullish doji Star 1W 48 Jun 25, 2023
Three Outside Up 15 48 May 30, 2024 06:45AM
Bullish Engulfing 1M 49 Apr 20
Advance Block Bearish 5H 49 Apr 29, 2024 11:00PM
Doji Star Bearish 1H 49 May 23, 2024 09:00AM
Belt Hold Bullish 15 49 May 30, 2024 06:30AM
Bullish Engulfing 15 49 May 30, 2024 06:30AM
Inverted Hammer 1D 50 Mar 14, 2024
Doji Star Bearish 1M 51 Feb 20
Advance Block Bearish 1W 51 Jun 04, 2023
Three Inside Up 15 52 May 30, 2024 05:45AM
Upside Gap Three Methods 1D 53 Mar 11, 2024
Evening Doji Star 30 53 May 28, 2024 07:30AM
Shooting Star 1W 54 May 14, 2023
Three Outside Up 1M 55 Oct 19
Harami Bullish 5H 55 Apr 25, 2024 09:00AM
Bullish Engulfing 1M 56 Sep 19
Advance Block Bearish 1D 58 Mar 04, 2024
Falling Three Methods 5H 58 Apr 24, 2024 08:00AM
Advance Block Bearish 1H 58 May 22, 2024 08:00AM
Harami Cross Bearish 15 58 May 30, 2024 04:15AM
Belt Hold Bearish 5H 59 Apr 24, 2024 03:00AM
Three Outside Down 30 60 May 28, 2024 04:00AM
Engulfing Bearish 30 61 May 28, 2024 03:30AM
Engulfing Bearish 5H 62 Apr 22, 2024 06:00AM
Belt Hold Bullish 1H 63 May 22, 2024 03:00AM
Engulfing Bearish 30 66 May 27, 2024 09:00AM
Bullish doji Star 1W 67 Feb 12, 2023
Bullish doji Star 15 68 May 29, 2024 09:45AM
Bullish Engulfing 1W 69 Jan 29, 2023
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

CHEMM Comments

Write your thoughts about ChemoMetec A/S
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
The Note
TheNote Jan 23, 2023 4:36AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Twitter - Chemometec - Come and meet us at booth no. 19 at the CAR-TCR Summit Europe, which will be held February 21 – 23, 2023, in London, UK.
Reply
0 0
Report
The Note
TheNote Jan 17, 2023 7:36PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Cordis - Horizon - Circular Vision - EU project with 4 million Euro to be presented 31. March 2024.
Reply
0 0
Report
The Note
TheNote Jan 17, 2023 6:24PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Chemometec presents for the tasks - NC202, Xcytomatic 40 and Xcyto5 and Xcyto10. The latter used in the patent taking of patterns.Eu is a very active contributor and the first cancer desease is under research. The results to be presented 2024 in collaboration with Roche Diagnostics.
Reply
0 0
Report
The Note
TheNote Jan 17, 2023 6:07PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Cirkular DNA - a biomarker - ready as diagnostic tool in 2024 ?Circular DNA is emerging as a novel biomarker for many types of cancer and inflammatory disorders. However, we lack the technology for detecting circular DNA and for generating appropriate disease models. To address this problem, the EU-funded CIRCULAR VISION project will use lung cancer and inflammatory bowel disease to investigate the link between disease and circular DNA. Scientists will combine microfluidics, DNA sequencing and bioinformatics to identify new biomarkers and develop novel approaches for cancer diagnosis. The generated technology will pave the way for future research and drug development in the field.
Reply
0 0
Report
The Note
TheNote Jan 17, 2023 5:50PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
2022 was a record year for the approval of never-before-authorized gene therapies, with three new therapies approved to treat rare diseases and another approved to treat bladder cancer. Additionally, five therapies that had already been approved in the US or Europe were authorized for the first time in a new geography or for another indication.But this is just the initial swell of the coming wave. As of this writing, as many as 13 brand new cell or gene therapies could be approved for use in the US, Europe, or both by the end of 2023. We are in reach of the FDA’s often-cited 2019 prediction that it would approve 10-20 new cell and gene therapies a year by 2025.
Reply
0 0
Report
The Note
TheNote Jan 17, 2023 5:48PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
There are now six FDA-approved CAR-T cell therapies available to patients in both the US and Europe to treat various blood cancers. They are but one part of a growing set of promising cell and gene therapies to address rare and prevalent conditions.There are over 2,000 clinical trials happening today, with 200 in Phase III – a wave of hope for patients waiting on durable, possibly curative treatments. But investment, policy, and regulatory challenges remain for the sector, and many patients will not benefit unless we modernize our approach to health care.
Reply
0 0
Report
The Note
TheNote Jan 17, 2023 5:09PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Report headlines to read, .. search for .. CAR-T Therapy market is projected to grow at a CAGR of 42.95% by 2032: Visiongain Reports Ltd
Reply
0 0
Report
The Note
TheNote Jan 17, 2023 2:06AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Weekly macd once again pointing upwards. The astonishing growth in Car-t and Gene therapeutics with + 40 % continues. The revolution in cirkular DNA diagnostics methods will in 2024 contribute to the growth. Together with the danish universities and ROCHE DIAGNOSTICS methods in cancer diagnostics and residual control will revolutionize medical timeframes a survivability. Cirkular DNA is to be found in 50 % of all cancer expressions. Due to their high technology and vast patenting Chemometec is ready to profit from these revolutionary methods. Read more at Chemotetec.dk
Reply
0 0
Report
The Note
TheNote Feb 08, 2022 6:49AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Confirmed break up from negative trade channel and weekly macd accelerating. Chart: https://invst.ly/xc7vy
Reply
0 0
Report
The Note
TheNote Feb 08, 2022 6:45AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
First halv year .. Interim .. growth 58 % and ebitda growth from 50 to 55 %. Preparing to launch the first automatick industrial scale advanced cell counter.
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email